197 related articles for article (PubMed ID: 36266040)
1. Ongoing Controversies in Esophageal Cancer II: Gastrectomy versus Esophagectomy for Siewert Type II Esophageal Adenocarcinoma.
Devaud N; Carroll P
Thorac Surg Clin; 2022 Nov; 32(4):553-563. PubMed ID: 36266040
[TBL] [Abstract][Full Text] [Related]
2. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
Haverkamp L; Seesing MF; Ruurda JP; Boone J; V Hillegersberg R
Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27001442
[TBL] [Abstract][Full Text] [Related]
3. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
[TBL] [Abstract][Full Text] [Related]
4. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
5. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
[TBL] [Abstract][Full Text] [Related]
6. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
[TBL] [Abstract][Full Text] [Related]
7. Surgical approach to advanced Siewert II cancer: beyond the borders? The West Side.
Hölscher AH; Bollschweiler E; Fetzner UK; Babic B
Updates Surg; 2023 Feb; 75(2):329-333. PubMed ID: 36001282
[TBL] [Abstract][Full Text] [Related]
8. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK
Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
[TBL] [Abstract][Full Text] [Related]
10. [Surgical strategy for adenocarcinoma of esophagogastric junction].
Lu Y; Zhang K; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):107-111. PubMed ID: 30799532
[TBL] [Abstract][Full Text] [Related]
11. Esophagectomy or Total Gastrectomy for Siewert 2 Gastroesophageal Junction (GEJ) Adenocarcinoma? A Registry-Based Analysis.
Kamarajah SK; Phillips AW; Griffiths EA; Ferri L; Hofstetter WL; Markar SR
Ann Surg Oncol; 2021 Dec; 28(13):8485-8494. PubMed ID: 34255246
[TBL] [Abstract][Full Text] [Related]
12. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
[TBL] [Abstract][Full Text] [Related]
13. [Surgical treatment strategies for Siewert type II adenocarcinoma of the esophagogastric junction].
Yan Q; Lyu ZJ; Zheng JB; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):1008-1012. PubMed ID: 33054000
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of Siewert type II adenocarcinoma of the esophagogastric junction: the perspectives from thoracic surgery].
Li ZY; Gu YM; Wang WP; Chen LQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):109-113. PubMed ID: 35176820
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.
Rüdiger Siewert J; Feith M; Werner M; Stein HJ
Ann Surg; 2000 Sep; 232(3):353-61. PubMed ID: 10973385
[TBL] [Abstract][Full Text] [Related]
16. Optimal surgery for esophagogastric junctional cancer.
Hayashi T; Yoshikawa T
Langenbecks Arch Surg; 2022 Jun; 407(4):1399-1407. PubMed ID: 34786603
[TBL] [Abstract][Full Text] [Related]
17. [Modern diagnostics and stage-oriented surgery: therapy of adenocarcinoma of the esophagogastric junction].
Hölscher AH; Fetzner UK
Chirurg; 2012 Aug; 83(8):702-8, 710-1. PubMed ID: 22878576
[TBL] [Abstract][Full Text] [Related]
18. Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers.
Hölscher AH; Law S
Gastric Cancer; 2020 Jan; 23(1):3-9. PubMed ID: 31691875
[TBL] [Abstract][Full Text] [Related]
19. [Advantages and disadvantages of transthoracic approach for adenocarcinoma of the esophagogastric junction].
Tan LJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):147-150. PubMed ID: 35176827
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas.
Karstens KF; Ghadban T; Sawez S; Konczalla L; Woestemeier A; Bachmann K; Uzunoglu FG; Tachezy M; Vettorazzi E; Izbicki JR; Reeh M
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):638-643. PubMed ID: 31879051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
